1. Home
  2. BOW vs NVAX Comparison

BOW vs NVAX Comparison

Compare BOW & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOW
  • NVAX
  • Stock Information
  • Founded
  • BOW 2020
  • NVAX 1987
  • Country
  • BOW United States
  • NVAX United States
  • Employees
  • BOW N/A
  • NVAX N/A
  • Industry
  • BOW Property-Casualty Insurers
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • BOW Finance
  • NVAX Health Care
  • Exchange
  • BOW Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • BOW 1.1B
  • NVAX 1.3B
  • IPO Year
  • BOW 2024
  • NVAX 1995
  • Fundamental
  • Price
  • BOW $39.54
  • NVAX $5.98
  • Analyst Decision
  • BOW Buy
  • NVAX Buy
  • Analyst Count
  • BOW 6
  • NVAX 6
  • Target Price
  • BOW $37.50
  • NVAX $17.83
  • AVG Volume (30 Days)
  • BOW 281.9K
  • NVAX 8.1M
  • Earning Date
  • BOW 05-06-2025
  • NVAX 05-08-2025
  • Dividend Yield
  • BOW N/A
  • NVAX N/A
  • EPS Growth
  • BOW 18.99
  • NVAX N/A
  • EPS
  • BOW 1.33
  • NVAX 2.97
  • Revenue
  • BOW $457,704,000.00
  • NVAX $1,254,962,000.00
  • Revenue This Year
  • BOW $25.34
  • NVAX N/A
  • Revenue Next Year
  • BOW $20.94
  • NVAX N/A
  • P/E Ratio
  • BOW $29.79
  • NVAX $2.01
  • Revenue Growth
  • BOW 45.29
  • NVAX 25.92
  • 52 Week Low
  • BOW $22.14
  • NVAX $4.43
  • 52 Week High
  • BOW $42.29
  • NVAX $23.86
  • Technical
  • Relative Strength Index (RSI)
  • BOW N/A
  • NVAX 43.78
  • Support Level
  • BOW N/A
  • NVAX $5.82
  • Resistance Level
  • BOW N/A
  • NVAX $7.50
  • Average True Range (ATR)
  • BOW 0.00
  • NVAX 0.56
  • MACD
  • BOW 0.00
  • NVAX 0.00
  • Stochastic Oscillator
  • BOW 0.00
  • NVAX 8.71

About BOW Bowhead Specialty Holdings Inc. Common Stock

Bowhead Specialty Holdings Inc offers commercial specialty property and casualty insurance products. The company offers underwriting solutions to various businesses across four underwriting divisions, which include Casualty, Professional Liability, Healthcare Liability, and Baleen Specialty. A majority of its revenue is generated from the Casualty division which specializes in general liability coverage, which protects a company against liability arising from bodily injury, personal injury or property damage, for risks in the construction, distribution, heavy manufacturing, real estate, public entity and hospitality segments and also considers underwriting risks in a broader range of industries. Geographically, the company operates in the United States.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: